维普期刊资源整合服务平台（V6.5）

45篇 您的检索式：作者名="Janmaat ML"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Response to epidermal growth factor receptor inhibitors in non-small cell lung cancer cells:limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular signal-regula-ted kinase or Akt kinase pathways显示文摘	Janmaat ML Kruyt FA Rodriguez JA	2003	Clin Cancer Res2003，9，6：	1
2	Predictive factors for outcome in a phase Ⅱ study of gefitinib in second - line treatment of advanced esophageal cancer patients显示文摘	Janmaat ML Gallegos-Ruiz MI Rodriguez JA	2006	Clin Oncol2006，24，10：	1
3	Predictive fac- tors for outcome in a phase II study of gefitinib in second-line treatment of advanced esophageal cancer patients 显示文摘	Janmaat ML Gallegos-Ruiz MI Rodriguez JA	2006	J Clin On- col2006，24，10：	1
4	The epidermal growth factor receptor pathway and its inhibition as anticancer therapy显示文摘	Janmaat ML Giaccone G	2003	Durg Today(Barc)2003，39，：	1
5	Re-sponse to epidermal growth factor receptor inhibitors in nonsmallcell lung cancer cells : limited antiproliferative effects and ab-sence of apoptosis associated with persistent activity of extracellu-lar signal-regulated kinase or Akt kinase pathways 显示文摘	JANMAAT ML KRUYT FAE RODRIGUEZ JA el al	2003	ClinCancer Res2003，9，6：	1
6	Inhibition of the epidermal growth factor receptor induces apoptosis in A431 cells but not in non-small-cell lung cancer cell lines 显示文摘	Janmaat ML Kruyt FAE Rodriguez JA	2002	Proc Am Assoc Cancer Res2002，43，：	1
7	Response to epidermal growth factor receptor inhibitors in non-smaU cell lung cancer cells: limited anfiproliferative effects and absence of apoptosis associ- ated with persistent activity of extracellular signal-regulated kinase or Akt kinase pathways显示文摘	Janmaat ML Kruyt FA RodriguezJA	2003	Clin Cancer Res2003，9，6：	1
8	Pre- dictive factors for outcome in a phase ]] study of gefitinib in second-line treatment of advanced esophageal cancer patients显示文摘	Janmaat ML Gallegos-Ruiz MI Rodriguez JA	2006	J Clin 0ncol2006，24，10：	1
9	Predictive factors for outcome in a phaseⅡstudy of gefitinib in secondline treatment of advanced esophageal cancer patients显示文摘	Janmaat ML Gallegos-Ruiz MI Rodriguez JA	2006	J Clin Oncol2006，24，10：	1
10	Response to epidermal growth factor receptor inhibitors in non-small cell lung Cancer cells:limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular signal-regulated kinase or Akt kinase pathways显示文摘	Janmaat ML Kruyt FA Rodriguez JA	2003	Clin Cancer Res2003，9，6：	1
11	Small-molecule epidermal growth factor receptor tyrosine kinase inhibitors 显示文摘	Janmaat ML Giaccone G	2003	Oncologist2003，8，6：	1
12	Predictive factors for outcome in a phase II study of gefitinib in second-line treatment of advanced ~ophageal cancer patients显示文摘	Janmaat ML Gallegns-Ruiz MI Rodriguez JA	2006	J Clin Oncol2006，24，10：	1
13	Predic- tive factors for outcome in a phase n study of gefitinib in sec- ond-line treatment of advanced esophageal cancer patients 显示文摘	Janmaat ML Gallegos-Ruiz MI Rodriguez JA	2006	J Clin Oncol2006，24，10：	1
14	Predictive factors for outcomein phase Ⅱ study of gefitinib in second-line treatment of advanced esophageal cancer patients 显示文摘	Janmaat ML Gallegos-Rulz MI Rodriguez JA	2006	J Clin Oncol2006，24，10：	1
15	Predictive factors for outcome in a Phase II study of gefitinib in second - line treatment of advanced e- sophageal cancer patients 显示文摘	Janmaat ML Gallegos - Ruiz MI	2006	J Clin Oncol2006，24，10：	1
16	Response to epi-dermal growth factor receptor inhibitors in non-small cell lungcancer cells:limited antiproliferative effects and absence of apop-tosis associated with persistent activity of extracellular signal-reg-ulated kinase or Akt kinase pathways显示文摘	Janmaat ML Kruyt FA Rodriguez JA	2003	Clin Cancer Res2003，9，：	1
17	Predictive factors for outcome in a phase II study of gefitinib in second - line treatment of advanced esophageal carlcer patients 显示文摘	Janmaat ML Gallegos - Ruiz MI Rodriguez JA	2006	J Clin Oncol2006，24，10：	1
18	Predictive factors for outcome in a phase Ⅱ study of gefitinib in second-line treatment of advanced esophageal cancer patients 显示文摘	Janmaat ML Gallegos - Ruiz MI Rodriguez JA	2006	J Clin Oncol2006，24，10：	1
19	Enhanced cytotoxicity induced by gefitinib and specific inhibitors of the Ras or phosphatidyl inositol - 3 kinase pathways in non - small cell lung cancer cells 显示文摘	Janmaat ML Rodriguez JA Gallegos - Ruiz M	2006	Int J Cancer2006，118，1：	1
20	Predictive fac- tors for outcome in a phase II study of gefitinib in second-line treat- ment of advanced esophageal cancer patients 显示文摘	Janmaat ML Gallegos-Ruiz MI Rodriguez JA	2006	J Clin Oncol2006，24，10：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示